Attention Deficit Hyperactivity Disorder - ADHD
Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997-2016
The prevalence of diagnosed ADHD in U.S. children and adolescents significantly increased over two decades, from 6.1% (1997-1998) to 10.2% (2015-2016).
Xu G, Strathearn L, Liu B, Yang B, Bao W. JAMA Network Open. 2018;1(4):e181471.
Among U.S. children and adolescents, the estimated prevalence of diagnosed ADHD increased significantly between 1997-1998 and 2015-2016, from 6.1% to 10.2%. The continuous increase in the prevalence of diagnosed ADHD was consistent across all subgroups.
A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders
Neurodevelopmental disorders are much more common in children who received mercury-containing vaccines.
Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. International Journal of Environmental Research and Public Health. 2014;11:9156-9170.
On a per microgram of organic-mercury (Hg) basis, pervasive developmental disorder, specific developmental disorder, tic disorder and hyperkinetic syndrome of childhood cases were significantly more likely than controls to receive increased organic-Hg exposure. This study provides new epidemiological evidence supporting a significant relationship between increasing organic-Hg exposure from vaccines and the subsequent risk of a neurodevelopmental disorder diagnosis.
Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink
A CDC-sponsored database showed much higher rates of neurodevelopmental disabilities from mercury-containing vaccines.
Young HA, Geier DA, Geier MR. Journal of the Neurological Sciences. 2008;121:626-631.
“Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg [mercury] exposure from TCVs [thimerosal-containing vaccines]. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs.”
Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal
Scientists identify vaccine mercury’s role in blocking crucial neurodevelopmental pathways.
M Waly, H Olteanu, R Banerjee, S-W Choi, JB Mason, BS Parker, S Sukumar, S Shim,
A Sharma, JM Benzecry, V-A Power-Charnitsky and RC Deth. Molecular Psychiatry , (2004) 9, 358–370.
“The ethylmercury-containing preservative thimerosal inhibited both IGF-1- and dopamine-stimulated methylation with an IC50 of 1nM and eliminated MS activity. Our findings outline a novel growth factor signaling pathway that regulates MS activity and thereby modulates methylation reactions, including DNA methylation. The potent inhibition of this pathway by ethanol, lead, mercury, aluminum and thimerosal suggest that it may be an important target of neurodevelopmental toxins.”